Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen's Plan to Divest Array Business Topped Most-Read GenomeWeb Daily News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Sept. 21.
 
1. Nanogen Mulls Sale or Closure of Microarray Business in Bid to Focus on Clinical Dx (from Sept. 18)
 
2. Alnylam and Merck Scuttle $120M-Plus RNAi Drug-Development Partnership (from Sept. 19)
 
3. NIH Sets Aside $574M to Expand Translational Research Consortium (from Sept. 19)
 
4. Clinton, Schumer Say VA's 'Stalling' on SUNY Genebank is Getting 'Ridiculous' (from Sept. 20)
 
5. Agilent to License ABI's RT-PCR Thermal Cycler IP as Part of Settlement (from Sept. 19)
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.